Page 18 - TD-4-3

Tumor Discovery FBXW7 in Leukemia

2. Choi HS, Kim BS, Yoon S, Oh SO, Lee D. Leukemic Rep. 2024;19(3):93-103.
stem cells and hematological malignancies. Int J Mol Sci. doi: 10.1007/s11899-024-00727-w
2024;25(12):6639.
14. Fallati A, Di Marzo N, D’Amico G, Dander E. Mesenchymal
doi: 10.3390/ijms25126639 stromal cells (MSCs): An ally of B-cell acute lymphoblastic
3. Iyer P, Jasdanwala SS, Wang Y, Bhatia K, Bhatt S. Decoding leukemia (B-ALL) cells in disease maintenance and
acute myeloid leukemia: A clinician’s guide to functional progression within the bone marrow hematopoietic niche.
profiling. Diagnostics (Basel). 2024;14(22):2560. Cancers (Basel). 2022;14(14):3303.
doi: 10.3390/diagnostics14222560 doi: 10.3390/cancers14143303
4. Hosseini A, Dhall A, Ikonen N, et al. Perturbing LSD1 and 15. Jabbour E, Kantarjian H. Chronic myeloid leukemia:
WNT rewires transcription to synergistically induce AML 2025 update on diagnosis, therapy, and monitoring. Am J
differentiation. Nature. 2025. Hematol. 2024;99(11):2191-2212.
doi: 10.1038/s41586-025-08915-1 doi: 10.1002/ajh.27443
5. Wiese W, Galita G, Siwecka N, Rozpedek-Kaminska W, 16. Kaehler M, von Bubnoff N, Cascorbi I, Gorantla SP.
Slupianek A, Majsterek I. Endoplasmic reticulum stress Molecular biomarkers of leukemia: Convergence-based
in acute myeloid leukemia: Pathogenesis, prognostic drug resistance mechanisms in chronic myeloid leukemia
implications, and therapeutic strategies. Int J Mol Sci. and myeloproliferative neoplasms. Front Pharmacol.
2025;26(7):3092. 2024;15:1422565.
doi: 10.3390/ijms26073092 doi: 10.3389/fphar.2024.1422565
6. Snaith O, Poveda-Rogers C, Laczko D, Yang G, Morrissette JJ. 17. Chen D, Wang MY, Tian C. Research progress of
Cytogenetics and genomics of acute myeloid leukemia. Best targeted therapy for chronic lymphocytic leukemia/small
Pract Res Clin Haematol. 2024;37(1):101533. lymphocytic lymphoma --review. Zhongguo Shi Yan Xue Ye
Xue Za Zhi. 2024;32(2):643-646.
doi: 10.1016/j.beha.2023.101533
doi: 10.19746/j.cnki.issn.1009-2137.2024.02.049
7. Longhitano AP, Slavin MA, Harrison SJ, Teh BW. Bispecific
antibody therapy, its use and risks for infection: Bridging the 18. Gueuning C, Lazaro E, Dupuy H, et al. Characteristics of
knowledge gap. Blood Rev. 2021;49:100810. large granular lymphocyte leukemia associated with variable
common immunodeficiency disorders: A study of 12 cases.
doi: 10.1016/j.blre.2021.100810
Eur J Haematol. 2024;113(4):550-557.
8. Xiao W, Nardi V, Stein E, Hasserjian RP. A practical approach doi: 10.1111/ejh.14265
on the classifications of myeloid neoplasms and acute
leukemia: WHO and ICC. J Hematol Oncol. 2024;17(1):56. 19. Boucher A, Murray J, Rao S. Cohesin mutations in acute
myeloid leukemia. Leukemia. 2024;38:2318-2328.
doi: 10.1186/s13045-024-01571-4
doi: 10.1038/s41375-024-02406-4
9. Chen L, Zeng P, Tang H, et al. Routes and molecular
mechanisms of central nervous system involvement in acute 20. Walter W, Iacobucci I, Meggendorfer M. Diagnosis of
myeloid leukemia (Review). Oncol Rep. 2024;52(5):146. acute lymphoblastic leukaemia: An overview of the current
genomic classification, diagnostic approaches, and future
doi: 10.3892/or.2024.8805
directions. Histopathology. 2024.
10. Demir D. Insights into the new molecular updates in doi: 10.1111/his.15338
acute myeloid leukemia pathogenesis. Genes (Basel).
2023;14(7):1424. 21. Tosello V, Di Martino L, Piovan E. Targeted metabolomics
of tissue and plasma identifies biomarkers in mice with
doi: 10.3390/genes14071424
NOTCH1-dependent T-cell acute lymphoblastic leukemia.
11. Pagliaro L, Chen SJ, Herranz D, et al. Acute lymphoblastic Int J Mol Sci. 2024;25(12):6543.
leukaemia. Nat Rev Dis Primers. 2024;10(1):41.
doi: 10.3390/ijms25126543
doi: 10.1038/s41572-024-00525-x
22. Yang F, Zhou H, Luo P, et al. Celastrol induces DNA damage
12. Cerqueira P, Pereira S, Costa R, et al. Cutaneous and cell death in BCR-ABL T315I-mutant CML by targeting
manifestation of acute lymphoblastic leukemia. Cureus YY1 and HMCES. Phytomedicine. 2024;134:155937.
2024;16(11): e74022
doi: 10.1016/j.phymed.2024.155937
doi: 10.7759/cureus.74022
23. Cortes-Lopez PN, Guzman-Montijo E, Fuentes-Venado CE,
13. Chen JJ, Tokumori FC, Del Guzzo C, Kim J, Ruan J. Update et al. Cutaneous fusarium disease and leukaemias:
on T-cell lymphoma epidemiology. Curr Hematol Malig A systematic review. Mycoses. 2024;67(7):e13759.

Volume 4 Issue 3 (2025) 10 doi: 10.36922/TD025150027